Company / Interest Expense
Century Therapeutics, Inc. Interest Expense History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$540.0K
FY2024
5-year range
$540.0K / $1.3M
FY2022-FY2024
Trend
-46.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1M to $540,000 over the past 2 years.
Based on SEC 10-K filings.
$540,000 in FY2024.
Improved from $1M to $540,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, interest expense decreased 46.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $540.0K | -46.9% |
| FY2023 | $1.0M | -20.2% |
| FY2022 | $1.3M | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026